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Migration of circulating leukocytes from the vasculature into
the surrounding tissue is an important component of the
inflammatory response. Among the cell surface molecules
identified as contributing to leukocyte extravasation is
VCAM-1, expressed on activated vascular endothelium,
which participates in all stages of leukocyte–endothelial
interaction by binding to leukocyte surface expressed
integrin VLA-4. However, not all VLA-4-mediated events can
be linked to VCAM-1. A novel interaction between VLA-4 and
endothelial Lutheran (Lu) blood group antigens and basal
cell adhesion molecule (BCAM) proteins has been recently
shown, suggesting that Lu/BCAM may have a role in
leukocyte recruitments in inflamed tissues. Here, we
assessed the participation of Lu/BCAM in the
immunopathogenesis of crescentic glomerulonephritis. High
expression of Lu/BCAM in glomeruli of mice with rapidly
progressive glomerulonephritis suggests a potential role
for the local expression of Lu/BCAM in nephritogenic
recruitment of leukocytes. Genetic deficiency of Lu/BCAM
attenuated glomerular accumulation of T cells and
macrophages, crescent formation, and proteinuria,
correlating with reduced fibrin and platelet deposition in
glomeruli. Furthermore, we found a pro-adhesive interaction
between human monocyte a4b1 integrin and Lu/BCAM
proteins. Thus, Lu/BCAM may have a critical role in
facilitating the accumulation of monocytes and
macrophages, thereby exacerbating renal injury.
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Necrotizing crescentic rapidly progressive glomerulonephritis
(RPGN) is a class of acquired renal disease that remains one
of few human autoimmune diseases that represent an acute
threat to survival.1 This has stimulated investigation into the
immunobiology of the condition in the hope of understanding
the pathogenesis not only of anti-glomerular basement mem-
brane disease, but also of other forms of glomerulonephritis
(GN) in which the aggravating antigen(s) is as yet unknown.
Focal necrotizing crescentic GN is the renal lesion typically
associated with the clinical syndrome of RPGN and is a
medical emergency that requires side effect–prone immuno-
suppressive therapies. Untreated RPGN progresses rapidly to
renal insufficiency. This process is almost always associated
with severe interstitial and periglomerular inflammation.
The inflammatory infiltrate gives way to a progressive fibrotic
process involving the crescents and the periglomerular and
peritubular interstitium, accompanied by tubular atrophy
and progressive renal failure. Although the pathogenesis
of crescentic RPGN is incompletely understood and likely
involves several convergent pathways, there is general agree-
ment that circulating mononuclear phagocytes have a central
role. Administration of nephrotoxic serum to rodents or
rabbits results in a severe proliferative and necrotizing GN that
is characterized by glomerular crescent formation and
accumulation of leukocytes.2–4 These infiltrating cells may
then release inflammatory mediators that influence the
behavior of glomerular, tubular, and interstitial cells. This
interaction between infiltrating and resident cells leads to
cellular proliferation, matrix expansion, and may ultimately
lead to glomerular sclerosis and interstitial fibrosis. Monocytes
and macrophages have a critical role as shown by ablation
of macrophages in murine crescentic GN that reduced renal
injury and improved renal function.5 Part of the deleterious
action of glomerular macrophages could be directly linked to
the augmented glomerular procoagulant activity as a result of
their expression of surface membrane procoagulant activity
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and by their potential to indirectly augment glomerular
procoagulant activity6 by the production of cytokines capable
of enhancing endothelial cell procoagulant activity.7 In
addition, infiltrating glomerular macrophages are the major
source of IL-18 and tumor necrosis factor (TNF).9 TNF-alpha
was shown to promote VCAM-1 and ICAM-1 glomerular
expression and the recruitment of PMNs and lymphocytes that
were markedly reduced in TNF-deficient mice in experimental
RPGN induced by anti-glomerular basement membrane
(GBM) antibody.10 Thus, strategies that reduce monocyte
infiltrates could be a promising avenue for complementary
therapy of RPGN. For example, neutralization of the
chemokine monocyte chemoattractant protein-1 (MCP-1)
resulted in a marked decrease in both glomerular crescent
formation and deposition of type I collagen.11 Another
strategy to prevent leukocyte infiltration in the kidney could
be to target endothelial molecules involved in cell adhesion.
Among the candidates, Lutheran (Lu) blood group antigens
and basal cell adhesion molecule (BCAM) antigen in
endothelial cells are carried by Lu/BCAM (CD239)
glycoproteins of the immunoglobulin superfamily. Lu/BCAM
glycoproteins are receptors of laminin alpha-5 chains, a major
component of the extracellular matrix.12 Notably, the second
ligand of Lu/BCAM is integrin a4b1. The a4b1 integrin or
very late antigen (VLA-4) or CD49d/CD29 is expressed mainly
on monocytes, lymphocytes, eosinophils, and immature
circulating sickle red cells.13 A novel interaction of a4b1
integrin in sickle red cells with endothelial Lu/BCAM
proteins has been recently shown to mediate sickle cell
adhesion to the endothelium.13 The expression of Lu/BCAM
in the mouse kidney has been localized in the glomerulus,
distal tubule, collecting duct, and in blood vessels.
Within glomeruli, Lu/BCAM is expressed at cell contact
with GBM, in particular, at glomerular endothelium.14
Thus, we hypothesized that an interaction between integrin
a4b1 and Lu/BCAM could be considered to promote
endothelial inflammation through a4b1-mediated adhesion
of leukocytes in experimental RPGN. We tested the effect
of the genetically determined Lu/BCAM deficiency on
crescentic RPGN induced by the infusion of nephrotoxic
serum (NTS) in mice.15
RESULTS
Attenuated RPGN and no renal failure in Lu / mice
A total of 12 Lu / and 14 wild-type (WT) male
littermates of mixed 129/Ola-C57BL/6J genetic background
had similar renal histology and functional parameters
(albuminuria to creatinine ratio, serum creatinine, and blood
urea nitrogen) at baseline (Figure 1). Injection of anti-
glomerular basement membrane (anti-GBM) nephrotoxic
serum (NTS) induced nephrotic syndrome in WT animals.
Nephrotic syndrome is caused by hypoproteinemia due to
massive urinary loss of large proteins, particularly albumin,
leading to hypoalbuminemia and ascites. Lu/BCAM defi-
ciency significantly prevented both the incidence and severity
of ascites (not shown) as well as the renal dysfunction
reflected by albuminuria (Figure 1a) and blood urea nitrogen
and serum creatinine concentrations (Figure 1b and c), which
were normal in Lu / mice.
As an index of early renal microvascular damage, we
measured renal blood flow velocity in the renal artery before
and on day 4 of NTS-induced RPGN. Whereas renal blood
flow velocity remained normal in NTS-challenged Lu /
animals, Luþ /þ animals displayed a significantly more
profound diminution of mean renal blood flow on day 4 than
that measured in Lu / counterparts (Figure 2). More
severe alteration of renal blood flow in Luþ /þ animals
was concomitant to equal, and later significantly higher,
systolic blood pressure levels compared with those measured
in Lu / mice (Figure 2). This suggests that Lu/BCAM
deficiency limited the early rise in renal vascular resistance.
We histologically examined WTmice injected with NTS, and
found severe GN by day 21 (Figures 3a–f), whereas Lu /
littermates had significantly less renal damage (Figure 3g–l).
Overall, Lu / mice displayed significantly fewer (3.5-fold
less) crescentic glomeruli (Figure 3m). Lu / mice also
exhibited fewer fibrocellular crescents (Figure 3n), no increases
in glomerular diameter, and virtually no rupture of Bowman’s
capsule (Supplementary Figure S1A and B online).
Reduced ultrastructural alterations in Lu / glomeruli
Because glomerular expression of Lu/BCAM is constitutive
and differential loss of glomerular permselectivity with heavy
albuminuria preceded the development of the crescents
already on day 7, we evaluated the morphological features of
podocytes in Luþ /þ and Lu / mice on day 4 after an
injection of NTS. Notably, podocyte ultrastructure was
normal and identical in Luþ /þ and Lu / mice under
control conditions with focal thickening of the external
lamina of the GBM in Lu / condition as previously
described.14 In response to NTS, WT Luþ /þ mice displayed
mild-to-severe effacement of the foot processes of podocytes
(Figure 3o). These ultrastructural alterations were markedly
attenuated in Lu / animals (Figure 3p). Consistently Lu/
BCAM deficiency was associated with fewer loss of
differentiated podocytes than in Luþ /þ mice after NTS
challenge, as assessed by WT-1 immunostaining on day 21
(Figure 3q and r).
Role of Lu/BCAM in the immuno-inflammatory response
associated with RPGN
Although T cells and macrophages are central players both in
our mouse model of NTS-induced GN and in human
crescentic RPGN,4,11,16 antibody deposition may also have a
pathophysiological role during the early stages of the disease,
promoting activation of complement.16,17 Therefore, we
assessed the humoral response of Lu / and Luþ /þ
mice to sheep IgG. Sheep IgG deposition in glomerular
basement membranes in the kidneys of both groups after
NTS injection displayed similar intensity and pattern
(Figure 4a). Glomerular deposition of mouse IgG was also
similar in both NTS-injected groups (Figure 4b). Serial
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dilutions of sera from pre-immunized animals showed
similar titers of mouse anti-sheep antibodies (Figure 4c).
Thus, we found no evidence that Lu/BCAM deficiency altered
the humoral immune response in this model.
Lu/BCAM glomerular expression remains localized in
endothelial cells during the course of RPGN
We evaluated whether change in Lu/BCAM expression would
occur in vivo during RPGN. Sequential assessment of
immunoreactive Lu/BCAM by immunofluorescence on day
0, 4, and 21 of experimental RPGN demonstrated prominent
endocapillary expression (Figure 5a). This pattern is consistent
with Lu/BCAM expression in endothelium and was also
observed by immunohistochemistry (Figure 5b). No signifi-
cant change in Lu/BCAM expression was found on day 4 in
glomeruli (Figure 5a) and cortex (Figure 5e and f). Lu/BCAM
glomerular expression did become faint on day 21 when
extensive glomerular capillary damage was found (Figure 5a).
Lu/BCAM expression favors glomerular fibrin and platelet
deposition
At sites of glomerular damage, the primary hemostatic
reaction involves platelet and fibrin deposition. At these sites,
circulating leukocytes marginate and become activated.
Furthermore, glomerular fibrin deposition is important in
the pathogenesis of renal failure and crescent formation in
GN.18 In addition, adhered platelets can support leukocyte
localization.19,20 Remarkably, although Luþ /þ nephritic
kidney displayed prominent fibrin immunoreactivity in 80%
of glomeruli after 3 weeks (Figure 6), Lu/BCAM-deficient mice
exhibited fewer fibrin and platelet deposition in glomeruli
than their WT counterparts 21 days after NTS challenge
(Figures 6 and 7). In contrast, glomeruli from Lu / mice
exhibited better preservation of podocin expression than that
observed in Luþ /þ mice (Figures 6c and 7c).
Lu/BCAM in the immune-inflammation associated with RPGN.
Lu/BCAM deficiency prevents macrophage and T-lymphocyte
infiltrates in the kidney
Macrophages and T cells are central players both in our
mouse model of NTS-induced GN and in human crescentic
RPGN.4,5,21,22 Therefore, to determine whether the
differences in immune cell infiltration may explain the
augmented glomerular and interstitial damage of the WT
group to NTS, the kidneys were stained for the immune cell
markers CD3 for T lymphocytes (Figure 8a and b) and F4/80
for resident macrophages (Figure 8c and d). CD3-positive
lymphocytes were present around the glomeruli and
throughout the renal interstitium in the NTS-infused WT
group, but not in the Lu / group (Po0.05; Figure 8b).
Lu/BCAM-deficient mice displayed fewer F4/80þ macro-
phages in the kidney cortex and around glomeruli than their
WT counterparts on day 21 after NTS injection (Po0.01;
Figure 8d). A similar picture was observed when using other
macrophage markers such as CD11b, CD68, and Mac-3
(Figure 9 and Figure 10), although at least clearly two distinct
populations of myeloid cells were recruited in Luþ /þ
nephritic kidneys but not in Lu / kidneys. F4/80- and
CD11b-positive cells surrounded parietal basal membrane of
diseased glomeruli and infiltrated the kidney interstitium. By
contrast, staining for CD68 and Mac-3 recognized a
population of not only interstitial but also intraglomerular
cells (Figures 9 and 10). Mac-3-positive cells were promi-
nently a part of crescentic structures (Figure 9c, detail).
Again, Lu/BCAM-deficient animals displayed significantly
fewer infiltrates of Mac-3-expressing cells in glomeruli
(Figure 10c). Although not fully co-localized, Mac-3
expression and fibrin deposition in glomeruli were highly
associated, irrespective of genotype (Supplementary
Figure S2). Thus, Lu/BCAM deficiency on renal endothelial
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Figure 1 | Deletion of Lu gene prevents severe renal failure. Albuminuria (a), blood urea nitrogen (BUN) concentrations (b), and serum
creatinine concentration (c) in NTS-challenged Luþ /þ and Lu / animals on day 4 and 21 after NTS, and in unchallenged controls
(day 0). Values are mean±s.e.m. (n¼ 10–14 per group). *Po0.05 versus Lu / at same time point. NTS, nephrotoxic serum.
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Figure 2 | Deletion of Lu gene prevents early fall in renal
perfusion. (a) Lu/BCAM deficiency significantly prevents the fall in
renal blood flow velocity (RBFV) in NTS-challenged nephritic mice on
day 4. Only wild-type Luþ /þ mice displayed relative reduction of
renal blood flow velocity (P¼ 0.036 for comparison of RBFV in
Lu þ /þ on day 0 versus Luþ /þ on day 4, paired sample Wilcoxon
signed-rank test), whereas Lu / mice did not (P¼ 0.147). On day
4, mean RBFV are different between groups (Mann–Whitney’s test;
P¼ 0.018) despite a similar degree of systolic pressure (b). *Po0.05
vs. Luþ /þ NTS-treated mice on day 4. #Po0.05 vs. day 0 (paired
sample). NTS, nephrotoxic serum.
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cells leads to marked diminution of the accumulation of
macrophages and T lymphocytes in the kidney despite severe
stimulus for experimental RPGN. In blood, Luþ /þ animals
displayed lymphopenia and granulopenia after 2 weeks of
experimental RPGN, whereas no such alterations were
observed in Lu / animals (Table 1).
Glomerular protection conferred by Lu/BCAM deficiency is
confirmed in congenic C57Bl6/J mice
To exclude genetic differences beside the Lu gene as an
explanation for the observed differences between Lu /
and WT Luþ /þ littermates of mixed 129/Ola-C57BL/6J
background, we applied the same passive anti-GBM nephritis
protocol to induce RPGN in Lu/ / and Luþ /þ of
congenic C57Bl6/J background. Again, Lu/BCAM deficiency
blunted part of the increase in albumin urinary excretion and
prevented renal failure as assessed by blood urea nitrogen level
(Supplementary Figure S3 online). Accordingly, Lu /
animals displayed fewer crescentic glomeruli and lower
fibrin and platelet deposition and glomerular infiltrates with
Mac-3-expressing cells (Supplementary Figure S4 online).
Lu/BCAM deficiency prevents increase in circulating classical
monocyte Ly6Chi subset and kidney entry of both the
classical and nonclassical monocyte subsets
Mouse monocytes comprise at least two phenotypically
distinct subsets: Ly6Chi 7/4hi CCR2þ CX3CR1lo and
Ly6Clo 7/4lo CCR2 CX3CR1hi monocytes. ‘Inflammatory’
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Figure 3 | Deletion of Lu gene prevents fatal glomerular destruction. Photomicrographs illustrating Masson trichrome staining of kidney
sections on different days after NTS in Luþ /þ (a–f) and Lu / (g–l) mice. In unchallenged animals (controls, CTR) and on day 4 no significant
damage was observed in both groups, but on day 21 Lu / NTS-treated mice displayed fewer and less severe glomerular and
tubulointerstitial lesions than their Luþ /þ counterparts that displayed 3.5 times as many crescents in glomeruli and more tubules with
proteinaceous casts (a–c and g–i; bar¼ 80mm); (d–f and j–l; bar¼ 20 mm). (m and n) Glomerular damage assessed by histopathological
evaluation of total crescent formation (m) and fibrocellular crescent formation (n) on day 21 after NTS infusion in NTS-injected Luþ /þ and
Lu / mice. **Po0.01 and ***Po0.001 versus Luþ /þ NTS-treated mice. (o and p) Ultrastructural analysis of podocytes and the glomerular
basement membrane by transmission electron microscopy (TEM) in NTS-treated Luþ /þ glomerulus (o) with representative effacement of the
foot processes (thick arrows) and focal thickening of the GBM (thin arrow). Such features were limited in Lu / glomeruli (p). Bars¼ 0.05 mm.
(q) Representative photomicrographs illustrating the progressive loss of WT-1 expression in Luþ /þ glomeruli (upper panels) and, to a milder
extent, in Lu / glomeruli upon NTS challenge. (r) Average number of WT-1-positive cells per glomerular section on day 21. *Po0.05 versus
Lu / on day 21, ##Po0.01 vs. respective group on day 0. Data are means±sem. NTS, nephrotoxic serum.
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Ly6Chi monocytes rapidly enter sites of inflammation, whereas
‘Resident’ Ly6Clo monocytes enter lymphoid and non-
lymphoid organs under homeostatic conditions and patrol
across the vascular endothelium.23 The specific role of each
monocyte subset in anti-GBM disease remains unclear. We
performed multicolor FACS analysis of classical (Ly6Chi
Ly6G CD11bþ CD115þ ) and nonclassical (Ly6Clow
Ly6G CD11bþ CD115þ ) subsets of monocytes in blood
and kidneys. In kidneys, Lu / displayed fewer monocyte
infiltrates of both subsets ( 36.5±7.2% and  29.6±5.8%
for Ly6Chi Ly6G CD11bþ CD115þ and Ly6Clow Ly6G
CD11bþ CD115þ , respectively, Po0.05 vs. Luþ /þ group),
with no significant change in subsets ratio. Luþ /þ mice
displayed higher Ly6Chi CD11bþ to Ly6Clow CD11bþ
populations ratio in blood on day 8 as compared with Lu /
animals (Po0.05) (Supplementary Figure S5 online).
Adhesion of peripheral human leukocytes to Lu/BCAM-Fc
under flow conditions
To determine whether Lu/BCAM glycoprotein could interact
with integrin a4b1, we performed flow adhesion assays of
human PBMCs using Lu/BCAM-Fc protein coated on plastic
microchannels. PBMCs, primarily monocytes, adhered to
coated Lu/BCAM-Fc in the presence of Ca2þ and Mg2þ
even in high shear stress conditions (4 dynes/cm2)
(Figure 11a). Preincubation of freshly isolated PBMCs with
recombinant Lu-Fc protein significantly reduced leukocyte
adhesion as compared with cells incubated with control Fc
fragment. As a positive control, leukocytes adhered to
VCAM-1-Fc (Vascular Cell Adhesion Molecule-1), a known
ligand for integrin a4b1. Under flow conditions, human
monocytes expressing integrin a4b1 adhered specifically to
immobilized Lu/BCAM-Fc proteins. Cell adhesion to Lu/
BCAM-Fc was inhibited by blocking monoclonal antibodies
anti-b1 integrin (Figure 11b) through a large range of
physiological shear stress (analysis of variance, ANOVA:
Po0.001 vs. adhesion after incubation with isotype-matched
control antibody).
DISCUSSION
Necrotizing crescentic RPGN is an inflammatory process
directed by cognate immune responses, which results in
severe glomerular injury and renal failure.1 In the past, the
participation of antibody and complement in human RPGN
was emphasized, leading to the view that humoral immune
effectors, principally immune complexes or anti-glomerular
basement membrane (GBM) antibody, were the predominant
pathogenic mediators in this severe form of GN. In fact, B
cell–deficient mice that have normal cell-mediated immunity
but cannot produce Ig develop crescentic anti-GBM GN to
the same extent as their normal littermates, confirming that
crescent formation can occur completely independent of
humoral immune responses.24 Thus, the involvement of T
cells and macrophages has been recognized, suggesting an
additional contribution of cell-mediated immunity.1,11,21,25–31
Although numerous studies have examined the role of
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soluble factors in mediating recruitment of lymphocytes and
macrophages in the kidney, the mechanisms whereby
myeloid cells interact with the renal endothelium in the
progression of RPGN are still not fully understood.
Considering the constitutive expression of Lu/BCAM on
the surface of endothelial cells in the kidney, we postulated
that they could be involved in the binding of integrins on
myeloid cell, contributing to their reinforced adhesiveness
to vascular endothelium. Our hypothesis was supported
by the presence of a4b1 consensus-binding motifs in the
extracellular domain of Lu/BCAM.32 Furthermore,
endothelial Lu/BCAM was recently shown to be a receptor
for the a4b1 integrin in red blood cells (RBCs), thereby
promoting adhesion of sickle RBCs to the endothelium.13
Regulation of a4b1 activation in vivo may promote leukocyte
adhesion.33 Likewise, a pathological role for the integrin
receptor Lu/BCAM is being realized in SS RBC aggregation to
monocytes in sickle cell disease.34 Erythroid Lu/BCAM
proteins are implicated in these aggregates through their
interaction with a4b1 integrin on peripheral blood
mononuclear cells. In the context of RPGN, monocyte
adhesion to the a4b1 ligands thrombospondin, VCAM-1,
and fibronectin or other factors in the vasculature may
markedly impact glomerular damage. Because mice
erythrocytes do not express Lu/BCAM, we hypothesize that
Lu/BCAM promotes glomerular inflammation and
demolition through its endothelial expression. Therefore, to
directly examine the actions of Lu/BCAM, a VLA-4/a4b1
integrin receptor on the endothelium in the pathogenesis of
RPGN, we used Lu / and Luþ /þ littermate mice and
then infused these mice with anti-GBM NTS. We observed
that genetic deficiency in Lu/BCAM prevents renal injury
(albuminuria, glomerular fibrinoid necrosis, and crescent
formation) along with reduced kidney infiltrates of T
lymphocytes and macrophages. In many kidney diseases,
the density of mononuclear cell accumulation correlates with
the degree of renal dysfunction and is predictive of disease
progression.31,35,36 Previous examination of the expression of
VCMA-1 in experimental RPGN has been performed during
the very early stages of nephritis. Infusion of antibody to the
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(red) and fibrin (green) in kidney cryosections from Luþ /þ and Lu / mice without (day 0) or with NTS-induced RPGN (on day 4 and day
21). Note that podocin expression was markedly more blunted in Luþ /þ than in Lu / on day 21. Bar¼ 80mm. NTS, nephrotoxic serum;
RPGN, rapidly progressive glomerulonephritis.
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Luþ /þ than in Lu / on day 21. Bar¼ 80 mm. NTS, nephrotoxic serum; RPGN, rapidly progressive glomerulonephritis.
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glomerular basement membrane in rats induced glomerular
upregulation of ICAM-1, ELAM-1, and VCAM-1 in a TNF-
alpha-dependent manner.37 Anti-VLA-4 mAb modestly
inhibited PMN migration and had no significant effect on
proteinuria. We did not observe any change in neutrophil
infiltrates in Lu/BCAM-deficient nephritic animals. However,
our study may have missed transient action on neutrophils as
studies of similar models of acute GN have revealed that
neutrophil recruitment to the glomerulus follows a rapid, yet
restricted, time course. Neutrophils accumulate in glomeruli
within hours of induction of inflammation, but are not
present 4–8 h later.38 More efficient than VLA-4 antagonism,
inhibition of Mac-1 was found to alleviate the GBM
antibody–associated increase in glomerular injury, demon-
strating an essential role for the elevation in neutrophil dwell
time in mediating glomerular injury.39,40 Thus, this latter step
is supposed to be independent of Lu/BCAM–VLA-4
interaction. Interestingly, a subsequent work demonstrated
that mAbs to VCAM-1 had no significant effect on
glomerular damage in a rat model of NTS-induced RPGN,
whereas mAbs to VLA-4 significantly attenuated renal
injury.41 This study concluded that a4b1 integrin/VLA-4 is
an important mediator of glomerular injury, operating after
transendothelial leukocyte migration, and that kidney
endothelial VCAM-1 has little part in early leukocyte influx
into glomeruli. In fact, the marked protection conferred by
Lu/BCAM deficiency suggests that this endothelial
glycoprotein could be an alternative ligand promoting
inflammation of the kidney vasculature.
To examine the type of macrophage recruited within
glomeruli, we performed immunohistochemistry for several
markers of macrophage, including CD68, Mac-3, CD11b,
and F4/80. Macrosialin/CD68 may not be a specific
marker for macrophages but rather an antigen indicative
of phagocytosis.42 It is expressed on tissue macrophages,
Langerhans cells, and at low levels on dendritic cells.
Nevertheless, in crescentic RPGN, this marker was
previously found to be expressed by virtually all CD45þ
monocytes/macrophages,43 whereas F4/80-expressing cells
represented a minority of CD45þmonocytes. Although
immunostaining techniques failed to provide evidence of
monocyte intraglomerular influx on day 4 when recruitment
of the innate immunity is intense, significant alleviation
of platelet and fibrin deposition at a later time point in
glomeruli from NTS-challenged Lu/BCAM-deficient mice
suggests that the Lu/BCAM molecule has a major
pathophysiological role in the process of microvascular
injury leading to RPGN. Accordingly, early concomitant
increase in renal vascular resistance index measured in
WT animals was alleviated in Lu/BCAM-deficient mice.
Macrophages have been shown to be responsible for
glomerular fibrin deposition in anti-GBM antibody–
induced GN.6,7 Likewise, significant fibrin deposition was
observed to be associated with glomerular macrophage
accumulation in our passive model of RPGN. Glomerular
tissue factor gene and protein expression were strikingly
increased in human crescentic RPGN, in particular within
the crescents and in the mesangial area in the proximity of
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Figure 8 | Lu/BCAM deficiency prevents T lymphocyte- and F4/80-positive macrophage infiltrates. (a) Immunostaining for CD3þ
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monocytes.44 Furthermore, fibrin deposition also trans-
lates thrombin activity that has been shown to aggravate
RPGN per se.45
Interestingly, Lu / animals displayed significantly
fewer intraglomerular CD68þ and Mac-3þ cells and much
fewer periglomerular and interstitial CD11bþ and F4/80þ
CD11b
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Figure 9 | Lu/BCAM deficiency prevents CD11b, CD68, and MAC-3-positive macrophage infiltrates. (a) Representative immunostaining for
CD11b-positive macrophages, (b) for CD68-positive macrophages and (c) for MAC-3-positive macrophages in renal cortex from NTS-injected
Luþ /þ and Lu / mice. CD11b-positive cells are primarily periglomerular and in the interstitium with a pattern close to F4/80-positive cells.
In contrast, CD68-positive cells are also intraglomerular in Luþ /þ nephritic kidneys only. (a and b): magnification x200, Bar¼ 80mm. (c) MAC-
3-positives cells are also intraglomerular and within cellular crescents in nephritic renal cortex from Luþ /þ animals. Magnification x400,
Bar¼ 50mm. Right panels: higher magnification for detailed view of representative glomeruli from NTS-treated mice. NTS, nephrotoxic serum.
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cells than did the Luþ /þ animals upon NTS challenge. This
suggests that Lu/BCAM may contribute to the recruitment of
distinct macrophage populations with a potential impact on
activation of the coagulation cascade.
By using cell sorting and FACS analysis, we then examined
whether Lu/BCAM expression would have influenced egress
of CD11bþ Ly6Chi monocytes from blood into inflamed
kidneys after NTS infusion. However, we found that the
recruitment of nonclassical monocytes approached the rate of
classical monocyte entry into the nephritic kidney with no
obvious effect of Lu genotype. It is uncertain whether both
subsets participate in glomerular disease progression from
the onset or whether the contribution of nonclassical
monocytes increases later. Surprisingly, a significantly higher
proportion of Ly6Chi monocytes from unchanged total
monocyte count was found in wild-type Luþ /þ nephritic
mice as compared with NTS-challenged Lu / mice,
suggesting that mobilization of this pro-inflammatory
monocyte subset was altered in Lu/BCAM-deficient animals.
This could be an indirect effect due to the blunted kidney
damage with less release of endogenous danger signal by
injured kidney cells. Overall, we could not find a sorting role
for Lu/BCAM on specific monocyte and macrophage
populations in the kidney. Further studies will be required
to determine whether Lu/BCAM expression may promote
preferential recruitment of specific monocyte subsets at
different time points. Deciphering whether Lu/BCAM had an
impact on the later F4/80 high population that originates
from the resident population derived from the yolk sac and is
not recruited from the circulation as reported recently by
Geissmann and coll.46 will also require further studies. As
F4/80þ macrophages develop and stay in close association
with epithelial structures and are associated with capillaries
throughout the microcirculation,47 they may be secondarily
responsive to Lu/BCAM-dependent capillary and epithelial
injury. Similarly, alleviation of endothelial and tissue injury
in Lu/BCAM-deficient kidneys may have had an impact on
the VLA-4 independent recruitment of T lymphocytes in the
interstitium. Overall, Lu/BCAM deficiency was sufficient to
prevent severe glomerular damage and renal failure in
mice. Furthermore, we describe a novel pathophysiological
interaction between leukocyte integrin a4b1 and endothelial
Lu/BCAM proteins. Integrin a4b1 is known to have
high affinity for VCAM-1, which is only expressed on the
surface of activated endothelial cells. As Lu/BCAM proteins
are expressed on both resting and activated cells, we
hypothesize that they could contribute to abnormal
adhesion of myeloid cells to resting endothelium either
by tethering myeloid cells or by reinforcing their adhesion
along with other described interactions to the glomerular
endothelium. These results indicate for the first time that
Lu/BCAM exhibits a broad pro-nephritic and pro-
inflammatory action in the course of experimental RPGN
and may represent a future therapeutic target in inflam-
matory diseases.
MATERIALS AND METHODS
Experimental animal models
Homozygous Lu / and their littermates WT mice Luþ /þ of
hybrid 129/Ola-C57BL/6J genetic background were generated by
heterozygous mating at the Institut Clinique de la Souris (ICS,
Strasbourg, France) as previously described.14 We used male mice
between 12 and 16 weeks of age.
After eight generations of backcrossing, by using marker-assisted
technologies on a C57Bl6/J background (N8), 10 homozygous
Lu / and 10 congenic littermate Luþ /þ mice were used in
another set of experiments.
Table 1 | Hematological parameters indicate that Luþ /þ animals displayed lymphopenia and granulopenia after 2 weeks of
experimental RPGN; such alterations were not observed in Lu / animals (Po0.05 vs. Luþ /þ at baseline)
Baseline Day 14 post NTS
Hematological parameters Luþ /þ (n¼ 11) Lu / (n¼ 13) Luþ /þ (n¼ 10) Lu / (n¼ 10)
Erythrocytes (x106/ml) 8.85±0.34 8.07±0.27 5.91±0.77 7.22±0.15
White blood cells (x103/ml) 8.35±0.66 7.77±0.34 5.04±0.76a 6.07±0.45
Monocyte (x103/ml) 0.62±0.05 0.76±0.11 0.59±0.15 0.74±0.12
Granulocytes (x103/ml) 0.46±0.06 0.49±0.05 0.25±0.07a 0.32±0.05
Lymphocytes (x103/ml) 7.14±0.43 7.42±0.52 3.83±0.58a 5.52±0.35
Platelets (x103/ml) 962.3±65.6 955.3±77.0 745.80±82.99 914.00±49.41
Abbreviations: Lu, Lutheran; NTS, nephrotoxic serum.
aPo0.05 vs. Luþ /þ at baseline.
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Passive anti-GBM nephritis protocol in mice has been popular-
ized and induced as described previously.11,48 Anti-GBM
nephrotoxic serum was injected through the retro-orbital venous
sinus at 6ml/g body weight for 3 days continuously as previously
described.15 We collected urine and blood on day 4, 7, 10, 14, and
21. On day 14 (C57Bl6/J mice) or on day 21 (129/Ola-C57BL/6J
mice), animals were euthanized. Experiments were conducted
according to the French veterinary guidelines and those
formulated by the European Community for experimental animal
use (L358-86/609EEC), and were approved by the Institut National
de la Sante´ et de la Recherche Me´dicale (INSERM).
Physiological parameter measurements
Cardiac and renal hemodynamic studies were assessed by echocar-
diography (Vivid 7, GE Medical Systems ultrasound, Velizy-
Villacoublay, France) equipped with a 12-MHz linear transducer
(12 l). The measurement procedure was described previously.49
Biochemical analysis
Urinary concentrations of albumin were normalized by creatinine
concentrations in individual samples. Albumin excretion was
expressed as grams per mol of creatinine. Serum creatinine and
urea concentrations were expressed as mmol/l and mmol/l,
respectively. Analyses were performed by the IBiSA core facility at
Institut Claude Bernard, Paris. Assessment of creatinine levels was
performed by using a mouse creatinine ELISA kit (Cusabio Biotech,
Wuhan, P.R. China).
Blood cell count analysis
The blood samples were collected through retro-orbital venous sinus
with 75ml sodium heparinized hematocrit capillaries (Hirschmann
Laborgerate, Eberstadt, Germany) into 1ml ETDA Minicollect tubes
at room temperature. The proportion of white blood cells, RBCs,
and platelets was assessed with the help of an electronic hematology
counter (type MS9-5; Melet Schloesing Laboratories, Osny, France).
Renal histology and morphological evaluation
The kidneys were fixed in formalin 10% v/v (Labonord,
Templemars, France) for at least 24 h, dehydrated, and sections of
3 mm were realized and stained with Masson’s trichrome. Glomerular
crescents were defined as glomeruli containing two or more layers of
cells in Bowman’s space and scored as severe glomerular involvement
when present. The crescent glomerulus ratio was calculated by
counting injury and normal glomeruli (60–70 glomeruli for each
kidney sample). The proportion of pathological glomeruli was
evaluated by examination of at least 60 glomeruli per section, by an
examiner masked to the experimental conditions (PLT). The
Histotlab software (Microvision, Evry, France) was used for
measurement of average glomerular radius and 50 to 60 glomeruli
were measured for each kidney sample (n¼ 12 per group).
Transmission electron microscopy
The preparation of the kidneys for transmission electron microscopy
was performed according to procedures as previously described.14
Western blotting
After 6 days of culture, the cell outgrowths from decapsulated
glomeruli were carefully separated and placed in 200ml Phospho-
SafeExtraction Reagent (Merck Biochemistry, Fontenay-sous-bois,
France) on ice, and lyzed with a sonicator. Total protein
concentration was measured with Novagen BCA Protein Assay Kit
(Merck Biochemistry). Protein amounting to 20 mg was subjected to
electrophoresis in Criterion XT precast gel (4–12% Bis-tris, Bio-
Rad). The proteins were transferred onto a polyvinylidene difluoride
(PVDF) membrane (Bio-Rad, Marnes-la-coquette, France). After
washing three times with phosphate-buffered saline Tween-20
(PBST), the membrane was blocked for 1 hour at room temperature
with 5% milk in PBST and then incubated with rabbit polyclonal
anti-murine (m) Lu antibody 455 (1:15,000, kindly provided by Yves
Colin-Aronovicz, Inserm, INTS), rabbit polyclonal to NPHS2
antibody (podocin) (1:2000, Abcam, Paris, France), rat monoclonal
anti-tubulin antibody (1:5000, Abcam) in PBST overnight at 4 1C.
After washing three times with PBST, the membrane was incubated
with ELC horseradish peroxidase–linked whole antibody (1:5000,
Amersham Biosciences, Glattbrugg, Switzerland) for 60min at room
temperature. The detection of specific signals was performed using
the Immun-Star WesternC Chemiluminescent Kit (Bio-Rad) with
an LAS-4000 imaging system (Fuji, Stamford, CT) used to reveal the
bands; densitometric analysis was used for quantification.
Immunofluorescence detection
For indirect immunofluorescence staining, kidney sections were
embedded in OCT (Sakura, AJ Alphen aan den Rijn, The
Netherlands) compound frozen in isopentane cooled in liquid
nitrogen. The frozen sections (5mm) were fixed with cold acetone
for 10min and then washed three times in PBS, blocked in 5% BSA
in PBS for 1 h at room temperature, and then incubated with
primary antibodies diluted in 1% BSA-PBS overnight at 4 1C: rabbit
polyclonal anti-murine (m) Lu antibody 455 (1:1500, kindly
provided by Yves Colin-Aronovicz), rabbit polyclonal to NPHS2
(podocin) antibody (1:2000, Abcam). After washing the unbound
antibodies three times in PBS, Cy3-conjugated secondary antibodies
(Chemicon International, Millipore SAS, Molsheim, France) were
used at a 1:1000 dilution for 1 h at room temperature. After
three washes, the cells were treated with the second primary
antibody FITC-conjugated polyclonal goat antiserum to mouse
fibrinogen (Nordic Immunological Laboratories, Susteren, The
Netherlands, 1:10) or anti-thrombocyte-FITC Ab (Cedarlane,
TEBU-BIO, Le Perray en Yvelines, France, 1:200) diluted in 1%
BSA-PBS and incubated for 30min at room temperature for double
immunofluorescence staining. The slides were mounted with
Fluoprep mounting medium, and analyzed using the Zeiss 2
fluorescent microscope, AxioCam HRC camera, and the Axiovision
4.3 software (Carl Zeiss S.A.S., Marly le Roi, France).
To detect Lu expression in podocyte, cells were cultured on m-
slides (Ibidi). After a 15min fixation with 2% paraformaldehyde,
cells were washed twice with PBS and incubated for 5min with 0.2%
triton (Sigma–Aldrich Chimie S.a.r.l., Saint-Quentin Fallavier,
France) in PBS. The same protocol for frozen kidney sections was
used for cultured cells.
To assess podocyte differentiation and leukocyte infiltration in
the kidneys, 4 mm paraffin-embedded kidney sections were cut,
dehydrated, and treated with target retrieval solution (Dako, Dako
France S.A.S., Les Ulis, France) for 20min at 98 1C in a water bath to
unmask specific antigens. After cooling, the sections were incubated
with peroxidase blocking reagent (Dako) for 20min and then in
10% goat serum-1% BSA in PBS for 1 h. The sections
were incubated overnight at 4 1C with anti-Wilms tumor-1
(WT-1) (1:500, Santa Cruz Biotechnology, Heidelberg, Germany),
anti-CD3 (1:100, Dako), anti-F4/80 (1:500, Serotec, Oxford, UK),
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MAC-3 (1:50, BD Pharmingen, Le Pont de Claix, France), CD11b
(1:100, Abcam), CD68 (1:100, Serotec), or fibrinogen (1:500, Dako)
antibody. Histofine reagents (Nichirei Biosciences, Tokyo, Japan)
were used and signal was detected in the presence of AEC substrate
chromogen (Dako). Sections were counterstained with hematoxylin
(Vector Laboratories, Eurobio, Courtaboeuf, France). The number of
WT-1-positive cells was counted in 30 glomeruli for each kidney
sample. The leukocyte infiltration quantification was accessed using
Image J software (NIH). Positively stained Mac-3 cells per 50
glomeruli of each mouse were counted and expressed per glomerular
cross-section. Glomerular fibrin deposition was assessed by studying
at least 50 glomeruli per mouse with the help of polyclonal rabbit
antihuman fibrin(ogen) Ab (1:500, Dako) according to a previously
published protocol.50 The degree of glomerular fibrin deposition was
scored semiquantitatively (on a scale of 0–3þ ) as follows: 0, no
fibrin deposition; 1, fibrin occupying up to one-third of the
glomerular cross-sectional area; 2, fibrin occupying one-third to
two-thirds of the glomerulus; and 3, greater than two-thirds of the
glomerular cross-section covered by fibrin.
For sheep IgG and mouse IgG staining, 5 mm kidney cryosections
were fixed in cold acetone for 10min, then washed in PBS and
blocked with 5% BSA-PBS for 1h at room temperature. Kidney
sections were then stained with Alexa Fluor 568 anti-sheep IgG,
Alexa Fluor 594 anti-mouse IgG (Invitrogen, Life Technologies SAS,
Saint Aubin, France, 1:500). After washing, the slides were mounted
with Fluoprep (Biome´rieux, Craponne, France) and analyzed using
the Zeiss 2 fluorescent microscope, AxioCam HRCcamera and the
Axiovision 4.3 software.
For double immunofluorescent staining, frozen kidney sections
(5 mm) were fixed with cold acetone for 10min and then washed
three times in PBS, blocked in 5% BSA in PBS for 1 h at room
temperature, and then incubated overnight at 4 1C with single or
mixed primary antibodies diluted in 1% BSA-PBS: rabbit polyclonal
anti-murine (m) Lu antibody 455 (1:1500, kindly provided by Yves
Colin-Aronovicz, Inserm, INTS) and rat anti-nidogen antibody
(1:500, Chemicon International) or rabbit polyclonal to NPHS2
antibody (podocin) (1:2000, Abcam). After washing three times,
unbound antibodies—secondary FITC- and Cy3-conjugated anti-
bodies (Chemicon International)—were added at a 1:500 and 1:1000
dilution for 1 h at room temperature.
Direct immunofluorescence microscopy was performed with
goat IgG against mouse fibrinogen, conjugated with FITC (Nordic
Immunology, 1:10) and FITC-conjugated anti-mouse thrombocyte
rat IgM (Cedarlane, 1:200) diluted in 1% BSA-PBS.
To examine the localization of fibrin and macrophages in
glomeruli, double fluorescent labeling was performed on 4 mm
kidney paraffin-embedded sections. Macrophage were detected with
anti-Mac-3 Ab (1:50, BD Pharmingen) and fibrin was detected with
polyclonal rabbit antihuman fibrin(ogen) Ab (1:500, Dako). The
secondary antibodies used were donkey anti-rabbit conjugated with
FITC and donkey anti-rat conjugated with Cy3 (both 1:500, Jackson
ImmunoResearch Europe, Suffolk, UK). The slides were mounted
with Fluoprep (Biome´rieux), and analyzed using the Zeiss 2
fluorescent microscope, AxioCam HRCcamera and the Axiovision
4.3 software.
Measurement of the murine anti-sheep IgG immune response
Serum mouse anti-sheep IgG levels were measured by enzyme-linked
immunosorbent assay15 by using plates (Nunc Maxisorb; Fisher
Scientific, Illkirch, France) coated overnight at 4 1C with 100mg/ml of
sheep IgG (Sigma). After blocking with 3% bovine serum albumin,
diluted serum samples were incubated for 1 h at 37 1C. For each
experiment a range of serum dilutions was tested with a standard
curve of a known positive sample. After washing, peroxidase-coupled
anti-mouse IgG (Fc-specific) (Rockland Immunochemicals,
Gilbertsville, PA) and peroxidase substrate were added.
Flow cytometry analysis
Kidney cortex were weighed, minced, and digested in 450U/ml
Collagenase I, 125U/ml Collagenase XI, 60U/ml DNAseI, and
60U/ml hyaluronidase (Sigma–Aldrich) for 1 h at 37 1C. Cells were
also isolated from venous blood. All cell suspensions were layered on
Histopaque 1083 (Sigma–Aldrich) for gradient density centrifuga-
tion. The mononuclear cell fraction was counted and stained using
anti-mouse CD11b-PercPCy5.5, Ly6G-PE, CD115-PE (BD Bio-
sciences, Le Pont de Claix), Ly6C-FITC or Ly6C-APC, or the
corresponding isotypes, and analyzed on a LSRII Flow Cytometer
(BD Biosciences) with the FacsDiva software (BD Biosciences).
CD11bhiLy6G NK1.1 CD115þ cells were considered to be
monocytes, and subset discrimination was made upon Ly6C
expression.
Adhesion assay under flow conditions
All adhesion assays were performed with 5ml freshly drawn EDTA-
anticoagulated venous blood from three healthy donors after
informed consent was obtained in accordance with the Declaration
of Helsinki. The study has been approved by the Scientific
Committee of the Institut National de la Transfusion Sanguine.
Lu-Fc was also purchased with human VCAM-1-Fc from R&D
Systems Europe (Lille, France).
Leukocyte adhesion to microslides coated with fusion protein
was measured under flow conditions with a capillary flow chamber.
Fc, Lu/BCAM-Fc, VCAM-Fc were coated into capillaries (micro-
slides: Sigma–Aldrich; internal channel dimensions: length 50mm,
width 5mm, height 0.2mm) at 4 1C overnight and microslides were
mounted as described.51 The leukocytes were separated from the
peripheral blood of healthy donors using Histopaque 1119
(Sigma–Aldrich). After hypotonic RBC lysis, 5106 cells/ml were
incubated with 2 mg/ml murine monoclonal antihuman IgG
(Immunotech, Marseille, France, clone 8a4) for 30min at 37 1C in
order to block Fc receptors. Washed cells were suspended in Hanks
buffer (10mM HEPES, 1mM MgCl2, 1mM CaCl2) with 5%BSA and
then incubated with1mM MnCl2 for 15min at 37 1C. Stimulated
cells were injected for 10min at shear stress of 0.2 dyne/cm2, and
5-minute washouts were carried out with Hanks buffer at 0.4, 1, 2,
and 4 dyne/cm2. After each washing step, adherent cells were
quantified in five representative areas along the centerline of
microslide with the help of the AxioObserver Z1 microscope and
AxioVision 4 analysis software (Carl Zeiss). Adhesion was totally
abolished when 1mM EDTA was added, indicating that the
interaction is dependent on divalent cations as expected with
integrins. For inhibition assays, cells were preincubated for 20min at
room temperature with 10 mg/ml anti-CD29/integrin b1–blocking
antibody (clone Mab13) or isotype-matched control antibody (BD
Pharmingen). Each adhesion experiment was performed three times.
Statistical analysis
Data are expressed as meansþ SEM. The two-tailed Mann–Whitney
test, the Wilcoxon signed-rank test and the Student t-test were used
as appropriate. For experiments with more than two subgroups,
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the nonparametric Kruskal–Wallis analysis of variance (ANOVA)
followed by Dunn’s multiple comparison test were used. Values of
Po0.05 were considered significant. All analyses were performed
using Prism version 5.04 for Windows, (GraphPad Software,
La Jolla, CA).
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SUPPLEMENTARY MATERIAL
Figure S1. (A). Average glomerular diameter before (day 0) and after
(day 4 and 21) the onset of RPGN.
Figure S2. Glomerular expressions of macrophage and fibrin in mice
with anti-GBM GN.
Figure S3. Lu/BCAM deficiency prevents functional features of RPGN
in C57Bl6/J mice.
Figure S4. Lu/BCAM deficiency attenuates glomerular
histopathological damage in C57Bl6/J mice.
Figure S5. (A) Representative FACS dot plots of CD45þ
Ly6GCD11bþ LyYCþ cells in blood from Luþ /þ and
Lu / mice on day 8 after NTS administration.
Supplementary material is linked to the online version of the paper at
http://www.nature.com/ki
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